2016 annual financial data
Relmada Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -16,216,000 USD and net income was -2,975,000 USD.
Operating cash flow was -13,143,745 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -16,216,000 USD
- Net income
- -2,975,000 USD
- Operating cash flow
- -13,143,745 USD